Compare Marsh & McLennan Companies, Inc. (MRSH) vs Tesla, Inc. (TSLA) Price & Performance

Marsh & McLennan (MRSH) trades at $188.81, down 1.04% today, but maintains a bullish technical trend with strong fundamentals. The company reported Q2 2026 EPS of $2.96, beating estimates, and has consistently exceeded earnings expectations. Revenue growth remains solid at 6% in Q2 2026, driven by risk and consulting services. Recent acquisitions, like the planned purchase of Accel Holdings, aim to expand its Midwest insurance reach.

The outlook is positive with a consensus price target of $202.89, suggesting 7.5% upside. Risks include margin pressure from rising expenses and soft P&C pricing. Analyst sentiment is mixed with 30.3% buy ratings but 66.7% hold, indicating cautious optimism. Institutional activity shows new positions by Ashton Thomas Securities and Bank of Nova Scotia, supporting long-term growth prospects.

Tesla (TSLA) trades at $332.71, up 0.56% on the day, as the stock shows mixed signals with bearish technical indicators but recent positive earnings beats. The company faces declining profit margins (net income margin of 3.67% in 2025) despite steady revenue near $95B, while valuation ratios remain elevated with a P/E of 308. Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV model.

Outlook remains bifurcated: long-term growth depends on AI and autonomy execution, but near-term risks include competitive pressures and high valuation. Analyst consensus price target of $393.87 suggests 18% upside, though technical weakness and earnings volatility warrant caution. Investment opportunity hinges on Tesla's pivot beyond automotive into robotics and energy.